21.3% Below Target

The consensus Wall Street price target for VIV is $15.27, representing 21.3% upside from the current price of $12.59. With 12 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

VIV has a consensus rating of "Hold" based on 12 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $15.27 implies 21.3% upside from current levels.

With a forward P/E of 2.3939x, VIV trades at a relatively low valuation. The consensus target of $15.27 implies 21.3% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $16.5 for VIV, while the most conservative target is $13.9. The consensus of $15.27 represents the median expectation. Our quantitative valuation model projects a bull case target of $112 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

VIV is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 5 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month VIV stock forecast based on 12 Wall Street analysts shows a consensus price target of $15.27, with estimates ranging from $13.9 (bear case) to $16.5 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $85, with bear/bull scenarios of $54/$112.

Our quantitative valuation model calculates VIV's fair value at $85 (base case), with a bear case of $54 and bull case of $112. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.

VIV trades at a forward P/E ratio of 2.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on VIV, with a "Hold" consensus rating and $15.27 price target (21.3% upside). 4 of 12 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

VIV analyst price targets range from $13.9 to $16.5, a 17% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $15.27 consensus represents the middle ground. Our model's $54-$112 range provides an independent fundamental perspective.